2006 Apr;22(4):213-8
Scientific discoveries made in recent decades say otherwise
This is where the conversation turns to peptides, and specifically, to a compound called BPC-157
European Commission Grants Approval for Oral Semaglutide in Weight Management Badari Andukuri Jul 16 2 min read The European Commission has issued marketing authorization for once-daily oral semaglutide 25 mg tablets, marketed under the Wegovy brand, for the management of obesity and weight-associated comorbidities in adults
has received support from the PyMiCCS project (grant number 01LS2109D), funded by the German Federal Ministry of Education and Research, as well as by the European Unions Horizon Europe research and innovation programme under grant no 101135512 (LegumES)
In a dramatic sequence of events that unfolded over just four days in early February 2026, online health and wellness company Hims & Hers launched, defended, and then abruptly withdrew a compounded version of Novo Nordisks newly approved Wegovy (semaglutide) pill for obesity